Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Research

Pathological impairments induced by interstitial implantation of 125I Seeds in spinal canal of banna mini-pigs

Authors: Zuozhang Yang, Yongqing Xu, Dakuan Yang, Hongpu Sun, Ruilian Zhao, Jin Zhang, Xiaoxue Wang, Hua Jiang, Lie Xu, Jinlei Zhang

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

Background

Use a banna mini-pig to set up 125I implantation model, and investigate the consequence of radiation-related impairments.

Methods

In present study, 125I seeds were implanted into spinal canal of T13 level of spine in banna mini-pigs. After operation, the pigs were raised up to 8 months, behavior changes were recorded within this period. After 8 months, spinal cords were collected for pathological analysis.

Results

In this study, a 125I brachytherapy animal model had been successfully established, in the model group, the banna pigs' Tarlov scale decreased from 5 to 2.57 ± 0.36, significant cellular impairments were noted by pathological analysis.

Conclusions

Without any protection and operation improvement, 125I implantation can cause serious histological impairments and moving difficulty for banna mini-pigs; this present research provides an alternative tool to study spinal 125I brachytherapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yang Zuozhang, Yang Dakuan, Xie Lin, Sun Yuqing, Huang Yunchao, Sun Hongpu, Liu Pengjie, Wu Zhongxiong: Treatment of metastatic spinal tumors by percutaneous vertebroplasty versus percutaneous vertebroplasty combined with interstitial implantation of 125I seeds. Acta Radiol. 2009, 50: 1141-1148.CrossRef Yang Zuozhang, Yang Dakuan, Xie Lin, Sun Yuqing, Huang Yunchao, Sun Hongpu, Liu Pengjie, Wu Zhongxiong: Treatment of metastatic spinal tumors by percutaneous vertebroplasty versus percutaneous vertebroplasty combined with interstitial implantation of 125I seeds. Acta Radiol. 2009, 50: 1141-1148.CrossRef
2.
go back to reference Jang JS, Lee SH: Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. J Neurosurg Spine. 2005, 2: 243-248. 10.3171/spi.2005.2.3.0243.CrossRefPubMed Jang JS, Lee SH: Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. J Neurosurg Spine. 2005, 2: 243-248. 10.3171/spi.2005.2.3.0243.CrossRefPubMed
3.
go back to reference Merrick GS, Wallner KE, Butler WM: Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol. 2003, 169: 1643-1652. 10.1097/01.ju.0000035544.25483.61.CrossRefPubMed Merrick GS, Wallner KE, Butler WM: Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol. 2003, 169: 1643-1652. 10.1097/01.ju.0000035544.25483.61.CrossRefPubMed
4.
go back to reference Roeloffzen EM, Monninkhof EM, Battermann JJ, van Roermund JG, Moerland MA, van Vulpen M: Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate. Int J Radiat Oncol Biol Phys. 2010, 80: 76-84.CrossRefPubMed Roeloffzen EM, Monninkhof EM, Battermann JJ, van Roermund JG, Moerland MA, van Vulpen M: Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate. Int J Radiat Oncol Biol Phys. 2010, 80: 76-84.CrossRefPubMed
5.
go back to reference Rivard MJ, Coursey BM, Hanson WF, Huq MS, Ibbott GS: Update of AAPM task group No. 43 report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004, 31: 633-674. 10.1118/1.1646040.CrossRefPubMed Rivard MJ, Coursey BM, Hanson WF, Huq MS, Ibbott GS: Update of AAPM task group No. 43 report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004, 31: 633-674. 10.1118/1.1646040.CrossRefPubMed
6.
go back to reference Rivard MJ, Davis SD, DeWerd LA, Rusch TW, Axelrod S: Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray Source: an electronic brachytherapy source. Med Phys. 2006, 33: 4020-4032. 10.1118/1.2357021.CrossRefPubMed Rivard MJ, Davis SD, DeWerd LA, Rusch TW, Axelrod S: Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray Source: an electronic brachytherapy source. Med Phys. 2006, 33: 4020-4032. 10.1118/1.2357021.CrossRefPubMed
7.
go back to reference Sun L, Li J, Cheng J: Monte Carlo calculations of the dosimetry parameters for the 125-I brachytherapy source. Journal of Tsinghua University(Science and Technology). 2006, 49: 1593-1596. Sun L, Li J, Cheng J: Monte Carlo calculations of the dosimetry parameters for the 125-I brachytherapy source. Journal of Tsinghua University(Science and Technology). 2006, 49: 1593-1596.
8.
go back to reference Maynard FM, Bracken MB, Creasey G, Ditunno JF, Donovan WH, Ducker TB, Garber SL, Marino RJ, Stover SL, Tator CH, Waters RL, Wilberger JE, Young W: International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association. Spinal Cord. 1997, 35: 266-274. 10.1038/sj.sc.3100432.CrossRefPubMed Maynard FM, Bracken MB, Creasey G, Ditunno JF, Donovan WH, Ducker TB, Garber SL, Marino RJ, Stover SL, Tator CH, Waters RL, Wilberger JE, Young W: International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association. Spinal Cord. 1997, 35: 266-274. 10.1038/sj.sc.3100432.CrossRefPubMed
9.
go back to reference Miki K, Kiba T, Sasaki H, Kido M, Aoki M, Takahashi H, Miyakoda K, Dokiya T, Yamanaka H, Fukushima M, Egawa S: Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial. BMC Cancer. 2010, 10: 572-PubMedCentralPubMed Miki K, Kiba T, Sasaki H, Kido M, Aoki M, Takahashi H, Miyakoda K, Dokiya T, Yamanaka H, Fukushima M, Egawa S: Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial. BMC Cancer. 2010, 10: 572-PubMedCentralPubMed
10.
go back to reference Barde YA, Dechant G: The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nature Neuroscience. 2002, 5: 1131-1136. 10.1038/nn1102-1131.CrossRefPubMed Barde YA, Dechant G: The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nature Neuroscience. 2002, 5: 1131-1136. 10.1038/nn1102-1131.CrossRefPubMed
11.
go back to reference Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F: Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes. 2002, 51: 2840-2845. 10.2337/diabetes.51.9.2840.CrossRefPubMed Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F: Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes. 2002, 51: 2840-2845. 10.2337/diabetes.51.9.2840.CrossRefPubMed
12.
go back to reference Charyulu K, Block N, Sudarsanam A: Preoperative extended field radiation with I-125 seed implant in prostatic cancer: a preliminary report of a randomized study. Int J Radiat Oncol Biol Phys. 1979, 5: 1957-1961. 10.1016/0360-3016(79)90945-3.CrossRefPubMed Charyulu K, Block N, Sudarsanam A: Preoperative extended field radiation with I-125 seed implant in prostatic cancer: a preliminary report of a randomized study. Int J Radiat Oncol Biol Phys. 1979, 5: 1957-1961. 10.1016/0360-3016(79)90945-3.CrossRefPubMed
13.
go back to reference Imamura K, McKinnon M, Middleton R, Black N: Reliability of a comorbidity measure: the Index of Co-Existent Disease(ICED). J Clin Epidemiol. 1997, 50: 1011-1016. 10.1016/S0895-4356(97)00128-5.CrossRefPubMed Imamura K, McKinnon M, Middleton R, Black N: Reliability of a comorbidity measure: the Index of Co-Existent Disease(ICED). J Clin Epidemiol. 1997, 50: 1011-1016. 10.1016/S0895-4356(97)00128-5.CrossRefPubMed
14.
go back to reference Bogart JA, Ungureanu C, Shihadeh E, Chung TC, King GA, Ryu S, Kent C, Winfield JA: Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma. J Neurooncol. 1999, 44: 53-57. 10.1023/A:1006285304892.CrossRefPubMed Bogart JA, Ungureanu C, Shihadeh E, Chung TC, King GA, Ryu S, Kent C, Winfield JA: Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma. J Neurooncol. 1999, 44: 53-57. 10.1023/A:1006285304892.CrossRefPubMed
15.
go back to reference Lee W, Daly BD, DiPetrillo TA, Morelli DM, Neuschatz AC, Morr J, Rivard MJ: Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003, 75: 237-42. 10.1016/S0003-4975(02)04098-5. discussion 242-243CrossRefPubMed Lee W, Daly BD, DiPetrillo TA, Morelli DM, Neuschatz AC, Morr J, Rivard MJ: Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003, 75: 237-42. 10.1016/S0003-4975(02)04098-5. discussion 242-243CrossRefPubMed
Metadata
Title
Pathological impairments induced by interstitial implantation of 125I Seeds in spinal canal of banna mini-pigs
Authors
Zuozhang Yang
Yongqing Xu
Dakuan Yang
Hongpu Sun
Ruilian Zhao
Jin Zhang
Xiaoxue Wang
Hua Jiang
Lie Xu
Jinlei Zhang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-48

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue